Prelude Therapeutics Incorporat

Q4 2025 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filers
48
Total reported value, excl. options
$82.6M
Manager Report Date Value ($000) Shares